De Sen Wan
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Surgical Treatments
-
- Immune cells in cancer
- Immune Cell Function and Interaction
Papers in
- Oncology 19
- Colorectal Cancer Treatments and Studies 9
- Colorectal Cancer Surgical Treatments 7
-
- Gastric Cancer Management and Outcomes 9
- Co-authors
- Xiao Wu (12 shared papers)Haiyen E. Zhau (1 shared paper)Gary J. Miller (1 shared paper)Andrew C. von Eschenbach (1 shared paper)Qiang Zhou (1 shared paper)Jing Hou (1 shared paper)Zhi Zhou (22 shared papers)Rui Peng (1 shared paper)
- Journals
- Molecular Carcinogenesis (1 paper)Journal of Translational Medicine (1 paper)Chemotherapy (1 paper)Diseases of the Colon & Rectum (1 paper)PubMed (30 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
De Sen Wan
33 papers receiving 407 citations
Peers
Comparison fields: 5 of 60
- Oncology 247
- Immunology 150
- Cancer Research 55
- Gastroenterology 15
- Pulmonary and Respiratory Medicine 85
Countries citing papers authored by De Sen Wan
This map shows the geographic impact of De Sen Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by De Sen Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites De Sen Wan more than expected).
Fields of papers citing papers by De Sen Wan
This network shows the impact of papers produced by De Sen Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by De Sen Wan. The network helps show where De Sen Wan may publish in the future.
Co-authors
The 25 scholars most cited alongside De Sen Wan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 173 | |
| 2 | 1992 | 76 | |
| 3 | 2007 | 29 | |
| 4 | 2004 | 19 | |
| 5 | [Cancer incidence and mortality in Guangzhou City from 2000 to 2002]. | 2008 | 15 |
| 6 | [Clinical features and treatment of 49 patients with anal canal adenocarcinoma]. | 2006 | 12 |
| 7 | [Efficacy and safety of adjuvant post-surgical therapy with imatinib in gastrointestinal stromal tumor patients with high risk of recurrence: interim analysis from a multicenter prospective clinical trial]. | 2006 | 11 |
| 8 | [Expression of estrogen receptor and progesterone receptor in colorectal cancer: a quantitative study]. | 2004 | 11 |
| 9 | [Multivariate regression analysis of recurrence following curative surgery for colorectal cancer]. | 2004 | 10 |
| 10 | [Correlation of tumor microvessel density to metastasis and recurrence of rectal cancer]. | 2004 | 7 |
| 11 | [Inhibitory effect of angiogenesis inhibitor YH-16 on liver metastases from colorectal cancer]. | 2006 | 5 |
| 12 | The role of half-life of carcinoembryonic antigen (CEA) in prognosis prediction of colorectal cancer patients with preoperatively elevated CEA. | 2008 | 5 |
| 13 | [Effects of tamoxifen on apoptosis and matrix metalloproteinase-7 expression in estrogen receptor beta-positive colonic cancer cell line HT-29]. | 2008 | 5 |
| 14 | [Multivariate prognostic analysis of patients with low and middle rectal cancer after curative resection]. | 2006 | 5 |
| 15 | [Lymphatic vessel density in Dukes' B rectal carcinoma and its correlation to prognosis]. | 2006 | 4 |
| 16 | [Expression of matrix metalloproteinase 1 in tissue of colon carcinoma and its clinical prognostic significance]. | 2011 | 4 |
| 17 | [Meta-analysis of postoperative adjuvant chemotherapy for Dukes' B colorectal carcinoma]. | 2005 | 2 |
| 18 | [Multivariate regressive analysis of prognosis of liver metastases from colorectal cancer]. | 2006 | 2 |
| 19 | [Mapping the sentinel lymph node ex vivo and finding the micrometastasis by CK-immunostaining in carcinoma of the colon and rectum]. | 2005 | 2 |
| 20 | [Efficacy and toxicity of FOLFOX6 regimen in treating colorectal cancer patients with liver metastasis]. | 2007 | 2 |
About De Sen Wan
De Sen Wan is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Cancer Research and Pathology and Forensic Medicine, having authored 35 papers that have together received 416 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (9 papers), Colorectal and Anal Carcinomas (9 papers), Gastric Cancer Management and Outcomes (9 papers), Colorectal Cancer Surgical Treatments (7 papers), Multiple and Secondary Primary Cancers (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Genetic factors in colorectal cancer (4 papers) and Cancer, Lipids, and Metabolism (4 papers). The work is most often cited by research in Oncology (247 citations), Immunology (150 citations), Cancer Research (55 citations), Gastroenterology (15 citations) and Pulmonary and Respiratory Medicine (85 citations). De Sen Wan has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Xiao Wu, Haiyen E. Zhau, Gary J. Miller, Andrew C. von Eschenbach, Qiang Zhou, Jing Hou, Zhi Zhou, Rui Peng, Ya Ding and Xing Zhang. Their work appears in journals such as Molecular Carcinogenesis, Journal of Translational Medicine, Chemotherapy, Diseases of the Colon & Rectum and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.